Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

399 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dasatinib in relapsed or plateau-phase multiple myeloma.
Wildes TM, Procknow E, Gao F, Dipersio JF, Vij R. Wildes TM, et al. Among authors: dipersio jf. Leuk Lymphoma. 2009 Jan;50(1):137-40. doi: 10.1080/10428190802563363. Leuk Lymphoma. 2009. PMID: 19152174 Clinical Trial. No abstract available.
Donor CMV serostatus has no impact on CMV viremia or disease when prophylactic granulocyte transfusions are given following allogeneic peripheral blood stem cell transplantation.
Vij R, DiPersio JF, Venkatraman P, Trinkaus K, Goodnough LT, Brown RA, Khoury HJ, Devine SM, Oza A, Shenoy S, Blum W, Adkins D. Vij R, et al. Among authors: dipersio jf. Blood. 2003 Mar 1;101(5):2067-9. doi: 10.1182/blood-2002-07-2110. Epub 2002 Oct 24. Blood. 2003. PMID: 12406871 Free article.
Recent advances in allogeneic hematopoietic stem-cell transplantation.
Devine SM, Adkins DR, Khoury H, Brown RA, Vij R, Blum W, DiPersio JF. Devine SM, et al. Among authors: dipersio jf. J Lab Clin Med. 2003 Jan;141(1):7-32. doi: 10.1067/mlc.2003.5. J Lab Clin Med. 2003. PMID: 12518165 Review. No abstract available.
Chimerism and clinical outcomes of 110 recipients of unrelated donor bone marrow transplants who underwent conditioning with low-dose, single-exposure total body irradiation and cyclophosphamide.
Girgis M, Hallemeier C, Blum W, Brown R, Lin HS, Khoury H, Goodnough LT, Vij R, Devine S, Wehde M, Postma S, Oza A, Dipersio J, Adkins D. Girgis M, et al. Blood. 2005 Apr 15;105(8):3035-41. doi: 10.1182/blood-2003-07-2346. Epub 2004 May 4. Blood. 2005. PMID: 15126314 Free article.
Granulocyte-colony-stimulating factor-mobilized prophylactic granulocyte transfusions given after allogeneic peripheral blood progenitor cell transplantation result in a modest reduction of febrile days and intravenous antibiotic usage.
Oza A, Hallemeier C, Goodnough L, Khoury H, Shenoy S, Devine S, Augustin K, Vij R, Trinkaus K, Dipersio JF, Adkins D. Oza A, et al. Among authors: dipersio jf. Transfusion. 2006 Jan;46(1):14-23. doi: 10.1111/j.1537-2995.2005.00665.x. Transfusion. 2006. PMID: 16398726 Clinical Trial.
Long-term remissions in patients with myelodysplastic syndrome and secondary acute myelogenous leukemia undergoing allogeneic transplantation following a reduced intensity conditioning regimen of 550 cGy total body irradiation and cyclophosphamide.
Hallemeier CL, Girgis MD, Blum WG, Brown RA, Khoury HJ, Devine SM, Vij R, Lin HS, DiPersio JF, Adkins DR. Hallemeier CL, et al. Among authors: dipersio jf. Biol Blood Marrow Transplant. 2006 Jul;12(7):749-57. doi: 10.1016/j.bbmt.2006.03.009. Biol Blood Marrow Transplant. 2006. PMID: 16785064 Free article.
399 results